As of November 6, 2026, CVS HEALTH Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on August 17, 2026, naming 1 appointment and 1 departure. The latest filing names Larry M. Robbins, leaving (Form 8-K, August 17, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like CVS HEALTH Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
CVS HEALTH Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-17. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as CVS HEALTH Corp files it.
Also on the record for CVS HEALTH Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 13, 2026 | Stake report, Schedule 13G/A, by Dodge & Cox | 3.9% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.51% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| July 16, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 8.3% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs CVS HEALTH Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on CVS HEALTH Corp and the records around it.
CVS HEALTH Corp elsewhere on the record
Companies that share a holder
- Dodge & Cox also filed stake reports on 36 other companies: Charter Communications, Inc. (Aug 2026), SUN COMMUNITIES, INC (Aug 2026), TransUnion (Jun 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch CVS HEALTH Corp
Get an email when CVS HEALTH Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on CVS HEALTH Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on CVS HEALTH Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CVS HEALTH Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-17 | Out | 8-K, 2026-08-17 | |||
| 2026-08-17 | In | 2026-11-18 | 8-K, 2026-08-17 |
New leaders reset buying decisions — get the Full Report on CVS HEALTH Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at CVS HEALTH Corp, with the record behind each one.
Find candidates like senior executive at CVS HEALTH CorpEvery change, in the filing's words
Departing: Larry M. Robbins
On August 13, 2026, Larry M. Robbins notified the Board of Directors (the "Board") of CVS Health Corporation (the "Company") of his resignation from the Board, effective immediately.
Appointed: Teresa Heitsenrether, effective 2026-11-18
On August 17, 2026, the Board appointed Teresa Heitsenrether to the Board, effective November 18, 2026.
- Mr. Robbins' resignation was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.
- Ms. Heitsenrether, age 61, is Executive Vice President and Chief Data & Analytics Officer of JPMorgan Chase & Co. ("JPMorgan Chase") and is a member of JPMorgan's Operating Committee.
- Prior to her current role, Ms. Heitsenrether held several senior leadership positions at JPMorgan Chase, including CEO of Securities Services and Global Head of Prime Brokerage & Equity Financing.
- She holds an M.B.A. from New York University and a B.S. in Finance from Fordham University.
- Ms. Heitsenrether was determined by the CVS Health Board to be "independent" under the Corporate Governance Rules of the New York Stock Exchange and under the Company's Corporate Governance Guidelines.
- Ms. Heitsenrether's compensation for service as a non-employee director of CVS Health will be consistent with that of the Company's other non-employee directors, subject to proration to reflect the commencement date of her service on the Board.
- The Company's director compensation practices are described under the caption "Non-Employee Director Compensation" in the Company's annual proxy statement filed with the U.S. Securities and Exchange Commission on April 3, 2026.
Tools for this story
Each opens in a new tab, filled in for CVS HEALTH Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.